Moexipril hydrochloride: Difference between revisions

Revision as of 15:30, 22 April 2014

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2], Amr Marawan, M.D. [3]

For patient information about Quinapril, click here.

Quinapril tablet is an angiontensin converting enzyme inhibitor drug that is FDA approved for the treatment of hypertension, heart failure, left ventricular dysfunction after myocardial infarction, diabetic nephropathy. Adverse reactions include hypotension, rash, hyperkalemia, disorder of taste, cough. hypotension, rash, hyperkalemia, disorder of taste, cough.

@@ Line 1: / Line 1: @@
 __NOTOC__
-{{Moexipril}}
+{{Quinapril}}
-'''''For patient information about Moexipril, click [[Moexipril (patient information)|here]].'''''
+'''''For patient information about Moexipril, click [[Quinapril (patient information)|here]].'''''
-{{SB}} Univasc<sup>®</sup> <ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = MOEXIPRIL HYDROCHLORIDE TABLET [APOTEX CORP.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d18108f5-98ca-1220-d145-bcf4e71ceaee#nlm34068-7 | publisher =  | date =  | accessdate = }}</ref>
+{{SB}} Univasc<sup>®</sup> <ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = ACCUPRIL (QUINAPRIL HYDROCHLORIDE) TABLET, FILM COATED [PARKE-DAVIS DIV OF PFIZER INC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=63cf5651-d52c-4d27-9fd4-ed9cd9724dff | publisher =  | date =  | accessdate =  }}</ref>
 ==References==